TABLE OF CONTENTS
Volume 16, Issue 5 (May 2009)
Original Articles
Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer
S Ganesh, M Gonzalez-Edick, D Gibbons, Y Ge, M VanRoey, M Robinson and K Jooss
Cancer Gene Ther 16: 383-392; advance online publication, November 14, 2008; doi:10.1038/cgt.2008.90
Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer
H Lu, C-S Chen and D J Waxman
Cancer Gene Ther 16: 393-404; advance online publication, November 14, 2008; doi:10.1038/cgt.2008.93
Drug–virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model
P Wonganan, W C Zamboni, S Strychor, J D Dekker and M A Croyle
Cancer Gene Ther 16: 405-414; advance online publication, December 26, 2008; doi:10.1038/cgt.2008.99
Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replication
H Zhang, K Takayama, L Zhang, J Uchino, A Harada, T Harada, J Hisasue, N Nakagaki, C Zhou and Y Nakanishi
Cancer Gene Ther 16: 415-422; advance online publication, January 16, 2009; doi:10.1038/cgt.2008.101
Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model
Z Li, J Xiang, W Zhang, S Fan, M Wu, X Li and G Li
Cancer Gene Ther 16: 423-429; advance online publication, December 19, 2008; doi:10.1038/cgt.2008.97
Transgene expression of 
tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity
J Xiang, M A Munegowda and Y Deng
Cancer Gene Ther 16: 430-438; advance online publication, December 19, 2008; doi:10.1038/cgt.2008.94
Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells
J C Symes, C Siatskas, D H Fowler and J A Medin
Cancer Gene Ther 16: 439-452; advance online publication, December 19, 2008; doi:10.1038/cgt.2008.96
Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells
E-H Park, S S Koh, R Srisuttee, I-R Cho, H-J Min, B H Jhun, Y-S Lee, K L Jang, C-H Kim, R N Johnston and Y-H Chung
Cancer Gene Ther 16: 453-461; advance online publication, December 19, 2008; doi:10.1038/cgt.2008.95
